Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × dehydroftorafur × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 5 Pancreatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Anus Neoplasms 2 Adenocarcinoma Of Esophagus 2 Tongue Neoplasms 1 Sinonasal undifferentiated carcinoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Paranasal Sinus Neoplasms 1 Pancreatic Intraductal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 HIV Infections 1 Fallopian Tube Neoplasms 1 Epstein-Barr Virus Infections 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡